Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Stephan

Showing results (91-100 of 146) with videos related to

Pageof 15
Sort By:
Plos One|July 23, 2013
Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysisHuw Price, David Dunn, Deenan Pillay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?, Amanda Mocroft, Peter Reiss, et al.
Journal of the International AIDS Society|June 12, 2021
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µLAndrew Atkinson, Jose M Miro, Amanda Mocroft, et al.
The Journal of Infectious Diseases|October 31, 2020
Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionLisa Henss, Tatjana Scholz, Christine von Rhein, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2023
Clinical characteristics and outcome of Mycobacterium chimaera infections after cardiac surgery: systematic review and meta-analysis of 180 heater-cooler unit-associated casesNils Wetzstein, Thomas A Kohl, Margo Diricks, et al.
AIDS (London, England)|January 26, 2026
Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/mL and history of K103N mutationGraeme Moyle, Lambert Assoumou, Nathalie De Castro, et al.
Infection|July 9, 2023
Pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ-CohortBenjamin T Schleenvoigt, Juliane Ankert, Grit Barten-Neiner, et al.
Lancet (London, England)|February 10, 2015
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 studyJean-Michel Molina, Chloe Orkin, David M Iser, et al.
Plos One|July 13, 2021
Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control studyNils Wetzstein, Ari Geil, Gerrit Kann, et al.
JHEP Reports : Innovation in Hepatology|June 12, 2023
Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 yearsChristiana Graf, Lara Fuhrmann, Thomas Lutz, et al.
Pageof 15

Showing results (91-100 of 146) with videos related to

Sort By:
Pageof 15
Plos One|July 23, 2013
Suppression of HBV by tenofovir in HBV/HIV coinfected patients: a systematic review and meta-analysisHuw Price, David Dunn, Deenan Pillay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 22, 2010
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL?, Amanda Mocroft, Peter Reiss, et al.
Journal of the International AIDS Society|June 12, 2021
No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µLAndrew Atkinson, Jose M Miro, Amanda Mocroft, et al.
The Journal of Infectious Diseases|October 31, 2020
Analysis of Humoral Immune Responses in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 InfectionLisa Henss, Tatjana Scholz, Christine von Rhein, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 14, 2023
Clinical characteristics and outcome of Mycobacterium chimaera infections after cardiac surgery: systematic review and meta-analysis of 180 heater-cooler unit-associated casesNils Wetzstein, Thomas A Kohl, Margo Diricks, et al.
AIDS (London, England)|January 26, 2026
Durable efficacy of dolutegravir/rilpivirine switch in subjects with HIV RNA <50 copies/mL and history of K103N mutationGraeme Moyle, Lambert Assoumou, Nathalie De Castro, et al.
Infection|July 9, 2023
Pathogen spectrum of community acquired pneumonia in people living with HIV (PLWH) in the German CAPNETZ-CohortBenjamin T Schleenvoigt, Juliane Ankert, Grit Barten-Neiner, et al.
Lancet (London, England)|February 10, 2015
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 studyJean-Michel Molina, Chloe Orkin, David M Iser, et al.
Plos One|July 13, 2021
Disseminated disease due to non-tuberculous mycobacteria in HIV positive patients: A retrospective case control studyNils Wetzstein, Ari Geil, Gerrit Kann, et al.
JHEP Reports : Innovation in Hepatology|June 12, 2023
Expanding epidemic of recently acquired HCV in HIV-coinfected patients over a period of 10 yearsChristiana Graf, Lara Fuhrmann, Thomas Lutz, et al.
Pageof 15